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Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis,
a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that
are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the
interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20.
Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at
lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently
increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with
chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with
changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono- to di-methylated
H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar
epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of
terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from
the stem cell compartment.
Citation: Frye M, Fisher AG, Watt FM (2007) Epidermal Stem Cells Are Defined by Global Histone Modifications that Are Altered by Myc-Induced
Differentiation. PLoS ONE 2(8): e763. doi:10.1371/journal.pone.0000763
INTRODUCTION
Many histone modifications, including acetylation, phosphoryla-
tion, ubiquitination, sumoylation, and methylation, are known to
regulate chromatin structure and gene expression [1,2]. This is
illustrated by modification of histone H3. When a gene is
transcriptionally active histone H3 is acetylated at lysines 9 and
14 and di- or tri-methylated at lysine 4. Conversely, in inactive
chromatin histone H3 is di- or tri-methylated at lysine 9 or 27 [2].
Epigenetic modifications are set by cell-type specific transcription-
al regulators and chromatin remodelling enzymes [3].
There is growing evidence that specific chromatin modifica-
tions distinguish stem and differentiated cells in a wide range of
tissues. In Drosophila, germ line and somatic stem cell self-
renewal are controlled by the chromatin remodelling factors
ISWI and DOM, respectively [4]. In neural stem cells epigenetic
marks are believed to be the main intrinsic factor regulating self-
renewal and differentiation [5]. In the haematopoietic system
quiescent B lymphocytes are characterised by global hypomethy-
lation at histone H3 [6]. Under-representation of repressive
histone marks could be indicative of epigenetic plasticity in stem
cells [7].
Mammalian epidermis provides an excellent model in which to
analyse the state and significance of chromatin modifications in
stem cells and their progeny. There are two reasons for this. The
first is that the location of at least two stem cell pools, in the hair
follicle bulge and in human interfollicular epidermis, is well
established [8,9,10]. The second is that activation of the
transcription factor Myc triggers exit from the epidermal stem
cell compartment and induces differentiation along the sebaceous
and interfollicular epidermal lineages [11,12]. Recent studies
suggest that Myc acts as a widespread regulator of gene
transcription [13,14], and both activation and repression of gene
expression contribute to the Myc-induced epidermal phenotype
[15,16,17]. The biochemical mechanism of Myc-mediated trans-
activation has revealed a wide range of effects on chromatin and
basal transcription [18]. Myc proteins are required for the
widespread maintenance of active chromatin [19].We therefore
set out to investigate whether adult epidermal stem cells have
common epigenetic modifications and how these change in
response to Myc activation.
RESULTS
Histone marks in human epidermis
We began by investigating whether stem cells in human
interfollicular epidermis were characterised by specific histone
modifications. We prepared epidermal whole mounts [9,20] and
labelled them with antibodies specific for histone H3 methylation
at lysines 4 (H3diK4) or 9 (H3diK9, H3triK9) and an antibody
that detects acetylation of H4 (H4Ac) (Figure 1).
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PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e763Human interfollicular epidermal stem cells express high levels of
ß1 integrins and are arranged in clusters in the epidermal basal
layer, surrounded by their progeny, transit amplifying (TA) cells,
and cells that have initiated terminal differentiation. Double
labelling for b1 integrins and antibodies to modified histones
revealed that although levels of H3diK4 or H3di, triK9
methylation varied, there was no correlation with high or low
expression of ß1 integrins (Fig. 1A–I). In contrast, cells that
expressed high levels of ß1 integrins had low levels of H4
acetylation (Fig. 1J–L). Therefore low levels of H4 acetylation are
a marker of human interfollicular epidermal stem cells.
Histone marks in the mouse hair follicle bulge
In mouse epidermis the best characterised pool of stem cells is not in
the interfollicular epidermis but in a region of the hair follicle known
as the bulge [8]. One characteristic of bulge stem cells is that if they
incorporate BrdU in neonatal epidermis they retain the label in
adulthood; such cells are known as label retaining cells (LRC)
[21,22]. We therefore examined the state of histone modifications in
label retaining cells (LRC) in whole mounts of mouse tail epidermis
(Fig. 2A–F) [22]. Antibodies to H3diK4, H3diK9 and H3triK9 gave
uniform labelling along the outer root sheath (ORS) of the hair
follicle, and most LRC, like the rest of the bulge cells, were strongly
labelled (Fig. 2A–C; line; insert). To quantify these results we
counted the total number of LRC per bulge and scored each cell as
strongly (high) or weakly (low) labelled (Fig. 2D–F, Fig. S1).
Whereas levels of histone methylation appeared to be uniform
in bulge cells, we detected heterogeneity amongst cells of the
interfollicular epidermis (IFE) (Figure 2G–I). The majority of
BrdU positive LRC in wild-type interfollicular epidermis were low
in H3diK4 or H3diK9 methylation (Fig. 2 G,H and M,N), but
high in H3triK9 (Fig. 2I,O).
We conclude that LRC in the bulge and the IFE represent
distinct cell populations when characterised by the level of H3
methylation.
Effect of Myc activation on epidermal histone marks
Epidermal stem cells can be stimulated to exit the stem cell
compartment by activation of the transcription factor Myc [23]. In
response to Myc, stem cells move into the TA compartment,
where they undergo several rounds of division and then
differentiate along the lineages of the interfollicular epidermis
and sebaceous gland [11,12,15,17]. To investigate the conse-
quences of overexpressing Myc on histone modifications in
epidermal cells, we prepared whole mounts of tail epidermis from
K14MycER mice that had been treated with 4-hydroxy-tamoxifen
(4OHT). The keratin 14 promoter drives transgene expression in
stem and transit amplifying cells in all regions of the epidermis.
MycER is a chimeric protein in which the C-terminus of Myc is
fused to a mutant oestrogen receptor; thus Myc is only activated
when cells are treated with 4OHT [11,12].
As reported previously [22], activation of Myc did not alter the
number or location of LRC in the bulge or IFE (Fig. 2D–F, M–O
and data not shown). In the bulge, the level of methylation of
H3diK4 and H3di, triK9 was similar in 4OHT treated K14MycER
mice and wild-type littermates (Fig. 2D–F). However, the IFE
differed from the bulge inits response to Myc. We still detected LRC
with low levelsofH3diK4and H3diK9methylation (Fig.2M,N),but
the proportion of cells with high levels of these modifications was
increased compared to wild-type control LRC (Fig. 2M,N).
The most dramatic effect of Myc was on H3triK9 methylation
of interfollicular epidermal LRC. The majority of LRC in Myc
activated epidermis were low in H3triK9 methylation, whereas in
controls most of the LRC had high levels (Fig. 2O). This suggests
that Myc increased H3diK9 methylation at expense of H3triK9
methylation.
Low levels of H4 acetylation are a mark of label
retaining cells in mouse epidermis that is regulated
by Myc
Since low H4 acetylation was common in stem cells in human
interfollicular epidermis (Fig. 1), we examined whether this was
also the case in mouse epidermis (Fig. 3A–D). The entire bulge
had much lower levels of histone acetylation than the rest of the
hair follicle (Fig. 3A,B; Bg). Double labelling for BrdU and H4Ac
demonstrated that LRC in both the bulge and interfollicular
epidermis of wild-type mice had low acetylation of H4 (Fig. 3C,D;
insert). We conclude that in human and mouse interfollicular
epidermis and in the mouse hair follicle bulge, stem cells are
characterised by low levels of histone H4 acetylation.
Acetylation of histone H3 and H4 is a chromatin modification
known to be mechanistically associated to Myc-induced transacti-
vation. Myc regulates gene transcription by recruiting the histone
acetyltransferases GCN5 and TIP60, and by directly up-regulating
GCN5 [19,24,25]. Therefore it was not surprising that in 4OHT
treated K14MycER epidermis there was increased H4 acetylation
of bulge LRC (Fig. 3D). Indeed, on activation of Myc the bulge
could no longer be distinguished on the basis of low H4 acetylation
(Fig. 3A,E; Bg), and acetylation was also increased in the
interfollicular epidermis (Fig. 3A,E; IFE).
We next asked whether H4 acetylation was correlated with
methylation at lysine 20 (K20). Mono-methylation of histone
Figure 1. Histone modifications in basal layer of human interfollicular
epidermis. Double label immunofluorescence staining of whole
mounts with antibodies to ß1 integrins (red) and (green) H3diK4 (A–
C), H3diK9 (D–F), H3triK9 (G–I) and H4Ac (J–L), with DAPI nuclear
counterstain (blue). C, F, I, L show merged images (left hand panels) and
higher magnification views (right hand panels). Scale bars: 20 mm.
doi:10.1371/journal.pone.0000763.g001
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coding regions of active genes and correlates with histone
hyperacetylation [26]. In the epidermis of wild-type mice, levels
of H4monoK20 correlated with acetylation of H4, being low in
the bulge (Bg) and high in other regions of the epidermis,
particularly the hair follicle bulb (Bb) (Fig. 3 B,F).
The increase in H4 acetylation resulting from activation of Myc
correlated with increased levels of H4monoK20 in bulge and
interfollicular epidermal LRC (Fig. 3G–I). However, the increase
was modest and did not occur throughout the whole epidermis
(Fig. 3J), leading us to speculate that H4monoK20 might
accumulate only transiently and be replaced with another modifi-
cation, such as H4di- or triK20. Since the number of LRC with
high levels of H4triK20 was decreased in 4OHT treated
K14MycER epidermis (Fig. 3K,L), we speculated that
H4monoK20 might be replaced by H4diK20.
Figure 2. Variation in histone H3 methylation in mouse epidermis and effects of Myc activation. Immunofluorescence staining for LRC (red) and
(green) H3diK4 (A, G, J), H3diK9 (B, H, K) and H3triK9 (C, I, L) in whole mounts of wild type (A–C, G–I) and 4OHT treated K14MycER (J–L) epidermis.
Position of hair follicle bulge is marked by line in A–C. Inserts in A–C show higher magnification views of bulge LRC. G–L show LRC in interfollicular
epidermis. (D–F, M–O) Quantitation (6S.D.) of number of LRC per bulge (D–F) and interfollicular epidermis (M–O) that had high or low levels of
staining (see Fig. S1) with antibodies to the H3 modifications indicated. Scale bars: 100 mm (A–C), 20 mm (G–L).
doi:10.1371/journal.pone.0000763.g002
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depends on HDAC activity
To demonstrate that H4diK20 was up-regulated in vivo, we
treated K14MycER and wild-type control mice for 6 days with
4OHT. H4diK20 was dramatically increased in K14MycER mice
compared to the controls (Fig. 3N,Q). Whereas nuclei high in
H4monoK20 were localised to the basal layer of the IFE in control
and transgenic mice (Fig. 3M,P), cells with high levels of H4diK20
were found in the differentiating, keratin 10 positive, suprabasal
layers of K14MycER mice (Fig. 3N–R).
The re-organisation of constitutive heterochromatin from
H4monoK20 to H4diK20 requires HDAC activity [27]. If Myc
replaces H4monoK20 with H4diK20, the process should be
Figure 3. Variation in histone H4 acetylation and methylation in mouse epidermis and effects of Myc activation. (A–C, E–G, I–K)
Immunofluorescence staining of whole mounts of wild-type (A–C, F, G, K) and 4OHT treated K14MycER transgenic (E,I, J) epidermis with antibodies
to (green) H4Ac (A–C, E), H4monoK20 (F, G, I, J) and H4triK20 (K). Double labelling for LRC (red) is shown in C, G, I, K. I and inserts in C, G, K show high
magnification views of LRC. IFE: interfollicular epidermis; sebaceous gland (SG), bulge (Bg), bulb (Bb) are marked with arrows in A, E. Hair follicles and
sebaceous glands are marked with dashed lines in A, B, E, F, J; LRC aremarked with dashed lines in C, G, I, K; position of bulge is marked with line in C, G,
K. D, H, L show quantitation (6S.D.) of number of LRC per bulge with high or low levels of the H4 modifications indicated. M–R: immunofluorescence
labelling (green) with DAPI counterstain (blue) of wild-type (M–O) and 4OHT treated K14MycER (P–R) dorsal interfollicular epidermis using antibodies
to H4monoK20 (M, P), H4diK20 (N, Q) and keratin 10 (O, R). Dashed lines indicate position of basement membrane. Scale bar: 50 mm
doi:10.1371/journal.pone.0000763.g003
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When we treated wild-type mouse epidermis with TSA, increased
numbers of cells with H4monoK20 were found in the IFE, hair
follicles and sebaceous glands (Fig. 4A,B). The effect was even
more pronounced when TSA was combined with Myc activation
(Fig. 4C,D).
To examine the mechanism by which Myc induced the switch
from H4monoK20 to H4diK20, cultured primary human
keratinocytes transduced with a MycER retroviral vector or an
empty vector control (pBabe) were labelled with antibodies to the
different states of H4 methylation (Fig. 4E–P). The number of cells
with high levels of H4diK20 increased by approximately 25% on
activation of Myc (Fig. 4I,K,R), an effect that was inhibited by
TSA (Fig. 4K,L,R). In both pBabe and Myc expressing keratino-
cytes, H4monoK20 increased on treatment with TSA (Fig. 4M–Q).
Replacement of H4monoK20 with H4diK20 in response to
Myc activation should be accompanied by activation of specific
histone methyltransferases. Set8 is an H4K20 specific mono-
methylase [29,30], while H4K20 di-methylation is dependent on
the histone methyltransferase Ash-1 [31]. Western blotting showed
that expression of Set8 was transiently up-regulated within 12
hours of activating Myc in keratinocytes (Fig. 5A; left hand panel).
Induction of the RNA methyltransferase Misu (NSun2), a direct
down-stream target of Myc [16], served as a positive control for
Myc activation in the Western blots (Fig. 5A; left hand panel).
TSA treatment had different effects on control keratinocytes
and keratinocytes with activated Myc. In control cells transduced
with pBabe, TSA caused a transient upregulation of Set8 (Fig. 5A;
right hand panel), which may reflect an initial increase in S phase
cells (detected as elevated Misu expression), followed by arrest in
G2+M of the cell cycle [16]. In TSA treated cells with activated
Myc, Set8 was highly expressed at 12 and 24 h (Fig. 5A; right
hand panel). The effect of activation of Myc on Ash-1 was to
stimulate nuclear accumulation, a process that was inhibited when
the cells were treated with TSA (Fig. 5B).
Inhibition of HDACs has similar effects on the
epidermal stem cell compartment to activation of
Myc
Our results show that acetylation of H4 and mono-methylation of
H4 at lysine 20 are low in epidermal stem cells, and that activation
of Myc or treatment with TSA increases both modifications. If the
modifications contribute to the mechanism of Myc-induced exit
from the epidermal stem cell compartment [11,23], then TSA
treatment of wild-type mouse epidermis should result in a similar
phenotype to Myc activation. Indeed we found that both TSA
treatment of wild-type epidermis and 4OHT treatment of
K14MycER epidermis led to a marked increase in the number
of cell layers in the interfollicular epidermis (Fig. 6A–C and E–G;
arrows), enlargement of the sebaceous glands (Fig. 6E–G; arrow-
heads and Q–S) and expansion of the hair follicle bulb (Fig. 6Q,R).
TSA treatment, like Myc activation, led to an increase in
proliferation, as measured by Ki67 labelling and incorporation
of a 1 hour pulse of BrDU into S phase cells (Fig. 6I–K, M–O;
arrowheads).
Activation of Myc in the presence of TSA exacerbated the
phenotype of K14MycER epidermis (Fig. 6D,H,L,P,T). There was
massive accumulation of cornified cells in the IFE (Fig. 6D); in
some areas no viable cell layers remained and the epidermis began
to detach from the underlying dermis (Fig. 6D; arrow). Both TSA
and Myc cause arrest of cultured keratinocytes in G2/M-phase of
the cell cycle, prior to initiation of terminal differentiation [16,23].
Consistent with these findings, the number of proliferative cells
was lower in K14MycER epidermis treated with 4OHT and TSA
(Fig. 6L,P) than with 4OHT alone (Fig. 6K,O). In addition to the
effects on the interfollicular epidermis, the combination of TSA
treatment and Myc activation resulted in further increases in the
number of differentiated sebocytes (Fig. 6H; arrowhead and 6T)
and aberrant hair follicle morphology (Fig. 6T).
We conclude that Myc-induced chromatin modifications play
a major role in Myc-induced exit from the stem cell compartment
and differentiation into interfollicular epidermis and sebocytes.
DISCUSSION
We have demonstrated that quiescent epidermal stem cells in both
the interfollicular epidermis and the hair follicle are characterised
Figure 4. Effects of TSA treatment and Myc activation on histone H4
modification. (A–D) whole mounts of wild-type (A, B) and K14MycER (C,
D) epidermis treated with 4OHT alone (A, C) or in combination with TSA
(B, D), labelled with antibody to H4monoK20 (green) and counter-
stained with DAPI (blue). Hair follicles and sebaceous glands (SG) are
outlined with dashed lines. Bg: bulge; Bb: bulb (A–D). (E–P) Double
immunofluorescence labelling of cultured human keratinocytes trans-
duced with empty vector (k-pBabe; E, F, I, J, M, N) or MycER (k-MycER; G,
H, K, L, O, P) and treated for 24 h with 4OHT alone (E, I, M, G, K, O) or
4OHT+TSA (F, J, N, H, L, P). Cells were stained with antibodies to
H4monoK20 (red) and H4diK20 (green) with DAPI counterstain (blue).
E–H are merged images of the panels below. (Q,R) Quantitation (6S.D.)
of % cells per colony with high levels of H4monoK20 (Q) or H4diK20 (R).
Cells were stimulated with 4OHT alone (4OHT) or 4OHT and TSA (TSA). P
values (t-test) are *0.0046, **0.0505 (Q) and *0.0545, **0.0211, ***0.0192
(R). Scale bar: 100 mm (A–D), 20 mm (E–P).
doi:10.1371/journal.pone.0000763.g004
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of H4 acetylation and H4K20 mono-methylation (Fig. 7). We
observed that whereas bulge LRC had high levels of di-methylated
H3K9 and H3K4, LRC in the IFE did not. While we do not have
a functional explanation for this difference, it is consistent with
reports of differences in the properties of stem cells in the bulge
and IFE and may reflect differences in sensitivity to intrinsic and
extrinsic factors [32,33,34].
In other cell types epigenetic plasticity is associated with under-
representation of repressive histone marks [6,7]. Epidermal stem
cells, however, had high levels of histone H3triK9 and H4triK20,
indicating that large sets of genes are repressed by Polycomb group
(PcG) complexes. In embryonic stem cells, PcG proteins regulate
stem cell pluripotency by maintaining repression of alternative
lineage genes that are necessary for differentiation of stem or
progenitor cells into various tissue types [35]. A similar situation
might exist in adult epidermis. Although epidermal stem cells have
the capacity to differentiate along multiple lineages, in un-
damaged, steady-state epidermis they appear to be specified to
differentiate along only one or a small number of lineages [10].
This would be consistent with our observation that the terminally
differentiated cells in the epidermis are, like stem cells, rich in
H3K9 and H4K20 trimethylation. It also raises the interesting
possibility that transit amplifying cells, being low in repressive
histone marks (Fig. 7), are more susceptible to lineage reprogram-
ming than stem cells [10].
In response to Myc activation epidermal stem cells enter the
transit amplifying compartment, leading to a transient increase in
proliferation followed by exit from the cell cycle and initiation of
differentiation [11,12,23]. Exit from the stem cell niche is
correlated with global histone H4 hyperacetylation, and transient
histone H4 monomethylation at lysine 20 followed by stable
dimethylation (Fig. 7). The increase in global histone H4
acetylation in response to Myc is in line with previous
observations. Histone acetylation is known to be enhanced by
Myc and is, at least in part, mediated by the direct up-regulation of
GCN5 by Myc [19,36]. Deletion of N-myc in neural progenitor
cells leads to chromatin changes associated with chromatin
inactivation, such as histone H3 and H4 hypoacetylation and
increased di- and tri-methylation at histone H3 at lysine 9 [19].
Myc has the highest affinity for target genesinopen, preacetylated
chromatin and further enhances histone acetylation [36]. However,
Myc binding and acetylation do not systematically correlate with
gene activation [36,37]. H4acetylation is also reported to distinguish
coding regions from heterochromatin independent of transcriptional
state [38]. Myc-induced hyperacetylation may therefore represent
a global epigenetic mark for coding regions that facilitates the
binding of transcription factors required for subsequent positive or
negative regulation of gene expression.
Although hyperacetylation of histone H4 has been found to
correlate with mono-methylation at lysine 20 in promoter and
coding regions of active genes [26], Myc-induced hyperacetylation
correlated with only a transient increase in mono-methylation and
with stable accumulation of nuclei with high levels of di-
methylated H4K20, H3K4 and H3K9 (Fig. 7). In contrast to
our observation that di-methylation increased in response to Myc,
high levels of H3diK9 and H3triK9 are also found in N-myc null
neural progenitors [19]. These results might indicate that di-
methylation, at least at H3K9, is not directly regulated by Myc or
involves additional factors. Nevertheless, the increased di-methyl-
ation in response to Myc in skin correlated with expression of the
corresponding histone methyltransferases Set8 and Ash-1 [29,30].
Our finding that di-methylation at different histones was
partitioned together might be a general mechanism of regulating
chromatin structures. Mono-methylated H4 at lysine 20 and H3
lysine 9 are partitioned together, as are the di-methylated forms,
whereas mono- and di-methylated forms are virtually mutually
exclusive [39]. In addition, chromatin marks that are associated
with highly active promoters partition together and allow high
affinity binding of transcription factors like Myc [40].
Histone acetylation can either be induced by Myc activation or
by inhibiting deacetylation via TSA. TSA treatment also led to
a major increase in the levels of H4monoK20 in the epidermis.
The strikingly similar effects of Myc and TSA in stimulating
proliferation followed by differentiation strongly suggest that
histone hyperacetylation is part of the mechanism by which
keratinocytes initiate terminal differentiation [11,41].
HDAC inhibitors are currently in clinical trials for various types
of cancer. These drugs can potentially reverse the resistance of
tumour cells to traditional chemotherapeutic drugs [42]. Our
Figure 5. Expression of histone methyl transferases in response to
Myc and TSA. (A) Western blots of keratinocytes infected with empty
vector (K-pBabe) or MycER (K-MycER) and treated with 4OHT6TSA for
the number of hours indicated. Blots were probed with antibodies to
the proteins indicated. Tubulin (Tub) was used as a loading control. (B)
Immunostaining for Ash-1 (red) with DAPI counterstain (blue). Scale bar:
10 mm.
doi:10.1371/journal.pone.0000763.g005
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beneficial because they promote differentiation. However, by
mobilizing stem cells to leave the niche the drugs could also have
the undesirable effect of compromising epithelial homeostasis in
healthy tissues.
Our data suggest that activation of Myc induces a widespread
change in chromatin state that is permissive for transcription
factor binding. In response to activated Myc chromatin modifica-
tions that are associated with both chromatin silencing and gene
activation were increased. This indicates that Myc induces an
intermediate state of facultative heterochromatin and might delay
the formation of obligate heterochromatin. This would explain
why the epidermis of K14MycER transgenic mice displays both
hyperproliferation and increased terminal differentiation. It would
Figure 6. TSA treatment induces similar changes in epidermal proliferation and differentiation to activation of Myc, and exacerbates the effects
of Myc. Wild-type (A, B, E, F, I, J, M, N, Q, R) and K14MycER transgenic (C, D, G, H, K, L, O, P, S, T) mice were treated with 4OHT alone (A, C, E, G, I, K, M,
O, Q, S) or in combination with TSA (B, D, F, H, J, L, N, P, R, T). 4OHT treatment of wild-type epidermis served as a negative control. A–P are sections of
back skin; Q–T are whole mounts of tail skin. Sections were stained with haematoxylin and eosin (A–H), anti-BrdU (brown, I–L) or anti Ki67 (brown, M–
P). Whole mounts were stained for keratin 14 (green) with DAPI counterstain (blue). Arrows in B, C, F, G, H show thickening of interfollicular epidermis.
Arrow in D shows detachment of epidermis from dermis. Arrowhead in F shows enlarged sebaceous gland. Arrowheads in J–L, N–P show different
numbers of proliferating cells. SG: sebaceous glands. Scale bars: 100 mm
doi:10.1371/journal.pone.0000763.g006
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pro-differentiative and pro-tumorigenic effects.
MATERIALS AND METHODS
Transgenic mice and treatment
K14MycER transgenic mice (2184C.1) [11] and nontransgenic
littermates (wild-type controls) received topical applications of
4OHT (Sigma, 1 mg per mouse per day) or trichostatin A (TSA)
(Sigma, 1mg per kg per day) to a shaved area of dorsal skin.
4OHT and TSA were dissolved in ethanol. When mice were
treated with both 4OHT and TSA, the animals received 4OHT or
TSA on alternate days over the treatment period of 6 days. Mouse
breeding and experimental protocols were subject to Institutional
ethical approval and were performed under the terms of a U.K.
Government Home Office licence.
BrdU labelling
To generate label-retaining cells (LRC), 10-day-old mice were
injected with 50 mg/kg (body weight) 5-bromo-29-deoxyuridine
(BrdU; 20 ml of 12.5 mg/ml BrdU) every 12 hours for a total of
four injections, as described previously [22]. In some experiments
mice were injected with BrDU one hour prior to sacrifice, in order
to label S phase cells.
Tissue preparation
Frozen sections (5–7 mm) of mouse dorsal and tail skin were fixed
for 10 minutes in 4% paraformaldehyde prior to labelling.
Wholemounts of mouse tail skin [22] and adult human skin [9]
were prepared as described previously. Human skin was obtained
as surgical waste from mastectomy operations with appropriate
ethical approval.
Immunostaining and image analysis
Immunostaining was performed as described previously [15,16].
Antibodies used were: H3diK4 (clone RR302; Upstate), H3diK9
(kindly provided by T. Jenuwein), H3triK9 (kindly provided by T.
Jenuwein), H4Ac (anti-acetyl-Histone H4; Upstate), ß1 integrin
(P5D2) [43], H4monoK20 (ab9051; Abcam), H4diK20 (ab14092,
Abcam), H4triK20 (ab9053; Abcam), Set8 (PR/SET07; Abgent),
Ash-1 (ab4477; Abcam), tubulin (Sigma), Misu (NSun2) (EF1) [16],
keratin 14 (MK14, Babco), keratin 10 (MK10, Covance), Ki67
(Novacastra), BrDU (Becton Dickinson) and Myc (N262, Santa
Cruz).
Images were acquired and expression levels were estimated
using a Zeiss 510 confocal microscope. Approximately 30 optical
sections of each epidermal sheet were captured with an increment
of 1 mm. Scans are presented as z-projections, scanned from the
dermal side towards the epidermal surface. The number of LRC
was counted per hair follicle bulge and per optical field in the
interfollicular epidermis (Zeiss 20/NA 0.75).
Human keratinocyte culture, retroviral infection and
Western blotting
Primary human keratinocytes were isolated from neonatal foreskin
and cultured in the presence of a feeder layer of J2-3T3 cells in
FAD medium (1 part Ham’s F12 medium, 3 parts Dulbecco’s
modified Eagle’s medium (DMEM), 1.8610
24 M adenine)
Figure 7. Model of histone modifications in different epidermal compartments and effect of Myc activation. Red arrows indicate events
stimulated by Myc. Stem cells and terminally differentiated cells are shown as having high levels of histone tri-methylation and low levels of histone
acetylation, mono- and di-methylation. Myc increases global H4 acetylation and transient mono-methylation of H4K20, which is replaced di-
methylation of H4K20, H3K4 and H3K9 at the expense of tri-methylation. HAT: histone acetyl transferase; HDAC: histone deacetyl transferase complex.
doi:10.1371/journal.pone.0000763.g007
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0.5 mg / ml hydrocortisone, 5 mg/ml insulin, 10
210 M cholera
toxin and 10 ng/ml epidermal growth factor (EGF) as described
previously [23]. J2-3T3 cells were cultured in DMEM containing
10% donor calf serum.
Keratinocytes were infected with the following retroviral vectors:
pBabe puro (empty vector) [44] and pBabeMycER [23]. Keratino-
cytes were infected by co-culture with retroviral producer cells as
described previously and used within one or two passages after
infection [23]. Activation of the steroid-inducible constructs was
performed by adding 200 nM 4OHT(Sigma) to the culture medium.
Keratinocytes were solubilised in RIPA buffer, resolved by SDS-
polyacrylamide gel electrophoresis and subjected to Western
blotting as described previously [15].
SUPPORTING INFORMATION
Figure S1 Quantitation of immunofluorescence labelling in
epidermal whole mounts. The fluorescence signal (y axes) along
lines (white arrows; x axes) crossing representative regions of the
bulge or interfollicular epidermis (IFE) double labelled for LRC
(red) and histone modifications (green) is shown. Peaks of
fluorescence correspond to nuclei. When the peaks of red and
green coincide an LRC has a high level of the histone modification
(asterisks), but when the red peak corresponds to a low level of
green the LRC has a low level of the modification (circle). This is
the basis for the histograms in Figures 2 and 3.
Found at: doi:10.1371/journal.pone.0000763.s001 (5.41 MB TIF)
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